Supply Chain | May 02, 2026
IMCD posts steady Q1 2026 performance with €130 million EBITA amid global uncertainty
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The company posted revenue of €1,267 million, up 6% on a constant currency basis
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Subscribe To Our Newsletter & Stay Updated
